Steven D. Nathan, MD

Medical Director, Lung Transplant Program
Medical Director, Advanced Lung Disease Program
Inova Fairfax Hospital
Falls Church, Virginia

Steven D. Nathan, MD, is the Director of the Advanced Lung Disease Program and the Medical Director of the Lung Transplant Program at Inova Fairfax Hospital in Falls Church, Virginia. Dr. Nathan received his medical degree at the University of the Witwatersrand Medical School in Johannesburg, South Africa. He completed his internship in Internal Medicine and General Surgery at the Johannesburg Hospital. Dr. Nathan performed his Internal Medicine residency at Long Island Jewish Hospital in New York City, and completed his fellowships in Pulmonary Medicine, Critical Care, and Lung Transplantation at Cedars-Sinai Medical Center in Los Angeles, California. He is board certified in Internal Medicine, Pulmonary Diseases, and Critical Care Medicine.

Dr. Nathan has been widely published in a number of peer-reviewed journals and publications, such as Chest and the Journal of Heart and Transplantation. He has since been awarded the Jubilee Award for his achievements from the University of the Witwatersrand. He also sits on the editorial board for Progress in Transplantation. Dr. Nathan is a member of several professional medical associations, including the American Thoracic Society and the International Society for Heart and Lung Transplantation, and is a member of the American College of Chest Physicians Network Interstitial Lung Disease Steering Committee.

STATEMENT ON CONFLICT OF INTEREST

It is the policy of The France Foundation that faculty are expected to disclose to activity participants any real or perceived conflict of interest related to the content of their presentations. In addition, all faculty are asked to disclose any discussion of unapproved uses of pharmaceuticals and devices.

Disclosure

Dr. Nathan has served as a consultant, has been on a speakers bureau, and has received grant support from InterMune, and has received research funding from Novartis and Wyeth.